ORTHOPEDICS
Focused Bone Health Support for Osteoporosis Care
Heveren’s Orthopedic division is committed to the management and treatment of Osteoporosis, a progressive bone disease that increases the risk of fractures due to low bone mass and structural deterioration. Our evidence-based formulations help restore bone strength and improve overall skeletal health, especially in postmenopausal women and the elderly.
Our orthopedics range
Osteoporosis
Osteoporosis is a major non-communicable disease and the mostcommon bone disease, affecting one in three women and one in five men over the age of 50 worldwide.
The clinical consequence of osteoporosis is fragility fractures.
With the rapid ageing of the population worldwide and the changes in lifestyle habits, the incidence of osteoporosis and related fractures has significantly increased and will continue to increase markedly in the future. Due to its prevalence worldwide, osteoporosis is considered a serious public health concern.
Worldwide, osteoporosis is estimated to affect 200 million women -approximately one-tenth of women aged 60, one-fifth of women aged 70, two-fifths of women aged 80 and two-thirds of women aged90.
In Asia, osteoporosis is greatly under-diagnosed and under-treated, even in the most high-risk patients who have already fractured.
Furthermore, the ageing of populations across the globe will be responsible for a major increase in the incidence of osteoporosis in postmenopausal women.
